Chao-hua N. Chiu
252, Wuxing Street, 110
Taipei, TNQ, Taiwan
Taipei, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 83 publications
Second Report of the American Intestinal Transplant Working Group: New Insights Into Risk Factors, Treatment Regimens, and Outcomes of Malignancy After Intestinal Transplantation.
Journal: Transplantation
Published: June 19, 2026
Plasma signals of lung tumor promotion for molecular cancer prevention.
Journal: Cell
Published: July 04, 2025
First-Line Lorlatinib Versus Crizotinib in Asian Patients With Advanced ALK-Positive NSCLC: Five-Year Outcomes From the CROWN Study.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: January 17, 2025
Preventing Infusion-Related Reactions With Intravenous Amivantamab-Results From SKIPPirr, a Phase 2 Study: A Brief Report.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: December 06, 2024
A Prospective Exploratory Study of Functional Immunity Assessed by Pretreatment Interferon Gamma Release Assay in Relation to Different Systemic Therapies in Patients With Advanced-Stage NSCLC.
Journal: JTO clinical and research reports
Published: November 20, 2024
The Taiwan Precision Medicine Initiative provides a cohort for large-scale studies.
Journal: Nature
Published: October 14, 2024
RELAY: Final Overall Survival for Erlotinib Plus Ramucirumab or Placebo in Untreated, EGFR-Mutated Metastatic NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: October 09, 2024
Durvalumab, Tremelimumab, and Platinum Chemotherapy in EGFR Mutation-Positive NSCLC: An Open-Label Phase 2 Trial (ILLUMINATE).
Journal: JTO clinical and research reports
Published: September 18, 2024
Incorporating High-Risk Individuals Beyond Smoking History Into Lung Cancer Screening in Hong Kong: A Cost-Effectiveness Study.
Journal: JTO clinical and research reports
Published: July 30, 2024
Hepatic Events During Immune Checkpoint Inhibitor Treatment Between Liver and Non-Liver Malignancies in Hepatitis B Endemic Areas.
Journal: Alimentary pharmacology & therapeutics
Published: July 07, 2024
Trouble with promoting lung cancer screening in never-smokers - Authors' reply.
Journal: The Lancet. Respiratory medicine
Published: February 09, 2024
Last Updated: 09/26/2026